Healthcare · Drug Manufacturers - General
Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Pharma & Managed Care · OBV Trend | UP 100% | OBV Trend — on-balance-volume accumulation. BMY ranks #1 of 13 in Pharma & Managed Care (100% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Quality | UP 92% | Quality — operating margin plus revenue growth. BMY ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · RSI Mean-Reversion | UP 83% | RSI Mean-Reversion — oversold up / overbought down. BMY ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile, RSI 55), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Trend Strength | UP 83% | Trend Strength — OLS slope of log price. BMY ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Bollinger Reversion | DOWN 75% | Bollinger Reversion — fade moves outside the bands. BMY ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Donchian | UP 75% | Donchian — position within the Donchian channel. BMY ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 25% | Long-Term Reversal — year-long losers rebound. BMY ranks #10 of 13 in Pharma & Managed Care (25% bullish percentile, signal -45.6%), so the agent calls it UP for the next session. |
Best agents on BMY (graded record)
| Mean-Reversion Agent | 100% | 1/1 correct | DOWN |
| Pharma & Managed Care · Mean-Reversion | 64% | 14/22 correct | DOWN |
| Pharma & Managed Care · LightGBM | 62% | 10/16 correct | UP |
| Pharma & Managed Care · Bollinger Reversion | 59% | 13/22 correct | DOWN |
| Pharma & Managed Care · Low Volatility | 57% | 4/7 correct | UP |
| Pharma & Managed Care · Long-Term Reversal | 56% | 18/32 correct | UP |
| Pharma & Managed Care · Quality | 56% | 23/41 correct | UP |
| Pharma & Managed Care · RSI Mean-Reversion | 56% | 14/25 correct | UP |
| Pharma & Managed Care · OBV Trend | 54% | 19/35 correct | UP |
| Pharma & Managed Care · MACD | 53% | 18/34 correct | UP |
Recent news
| 2026-08-21 | What Could Bristol Myers Squibb (BMY) AI Antibody Deal Mean For Drug Discovery? · yf_tkr_BMY |
| 2026-08-20 | Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery · yf_tkr_BMY |
| 2026-08-20 | Turn Bristol-Myers Squibb into an Income Machine with This Options Play · yf_tkr_BMY |
| 2026-08-19 | Notable Wednesday Option Activity: WMT, MDT, BMY · nasdaq_markets |
| 2026-08-19 | Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma · yf_tkr_BMY |
| 2026-08-19 | Bristol Myers Squibb to build $2.3B manufacturing campus in Houston · yf_tkr_BMY |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。